Instalim, AI x 3D Printed Prosthetics Developer, Raises Funds from Orthomos Investment and Partners with Alcare

Instalim Inc. (Headquarters: Sumida-ku, Tokyo; CEO: Yasushi Tokushima), a company expanding the world's first AI-based 3D printed prosthetic manufacturing solution in Japan, India, and the Philippines, has raised funds through J-KISS type stock acquisition rights from Orthomos Investment Co., Ltd. (Headquarters: Sumida-ku, Tokyo; CEO: Takamitsu Kaiga). Additionally, the company announced the signing of a basic agreement with Alcare Co., Ltd. (Headquarters: Sumida-ku, Tokyo; CEO: Katsumi Ito), a member of the Orthomos Group.

This investment and agreement serve as a critical foundation for Instalim to full-scale its digital manufacturing solution for prosthetics and orthotics in the Japanese market, following its success primarily in the Global South.

### Background of Funding and Business Alliance To achieve its vision of "a world where everyone who needs them can obtain high-quality prosthetics and orthotics," Instalim currently operates three main business pillars from its offices in India and the Philippines: 1. **Clinic Business:** Manufacturing and direct sales of high-quality, low-cost 3D printed prosthetics. 2. **Licensing Business:** Providing 3D design and manufacturing solutions and selling materials. 3. **Franchise Business:** Providing end-to-end solutions and know-how to new prosthetic manufacturing and sales facilities.

In the Clinic Business, the company has provided over 9,000 3D prosthetics in the Philippines and India, gaining a significant market share. In the Licensing Business, its solutions have been adopted by major organizations such as the Artificial Limbs Manufacturing Corporation of India (ALIMCO) and Jaipur Foot (BMVSS), rapidly expanding its presence in Asia.

In the Japanese market, challenges remain, such as maintaining supply chains amidst advanced medical needs and insufficient systems for prosthetic socket fitting and continuous use. By combining Instalim's digital manufacturing technology with the expertise and networks of partners in Japan, the company aims to present a new approach to these issues.

The investment from Orthomos Investment and the agreement with Alcare—a company with a 70-year history since developing Japan's first gypsum bandage—mark a significant milestone for Instalim to build its business foundation in Japan.

### Details of the Basic Agreement with Alcare The two companies will jointly study the following three points, aiming to create value beyond traditional frameworks by combining Instalim's AI, 3D-CAD, and 3D printing technologies with Alcare's expertise in skin physiology, ergonomics, and its established business network in Japan:

1. **Joint Study of Adjustable Prosthetic Socket Solutions:** Developing new solutions that allow patients and medical professionals to adjust fit for difficult cases. 2. **Joint Study of Digital Technology for Orthotics and Welfare Equipment:** Developing long-term equipment for deformations caused by aging or chronic illnesses. 3. **Joint Study of Business Development in the Japanese Market:** Strategizing the entry and expansion within Japan.